GlassScriptPhysician profile
Timothy P Zajonc
NPI 1336117779
$3,772.15
in general payments reported to CMS, 2019-2025
18 companies · $408 in 2025
The $408 reported for 2025 was more than what a typical Otolaryngology provider received nationally (typical 2025 total: $317).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,157 · 2020: $44.71 · 2021: $122 · 2022: $1,469 · 2023: $408 · 2024: $164 · 2025: $408.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $901 · Education: $78.02.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $901.23 |
| Education | $78.02 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $1,288.49 | 2022 | |
| Inspire Medical Systems, INC. | $1,142.46 | 2019-2025 | Inspire |
| Glaxosmithkline, LLC. | $312.80 | 2021-2025 | Nucala |
| Genzyme Corporation | $253.76 | 2019-2024 | |
| Acclarent, INC | $203.60 | 2019-2023 | Acclarent Navwire |
| Regeneron Healthcare Solutions, INC. | $196.54 | 2021-2024 | Dupixent |
| Aerin Medical INC. | $56.79 | 2019-2025 | |
| Amgen INC. | $51.00 | 2025 | |
| Advanced Bionics, LLC | $49.08 | 2022 | |
| Smith+Nephew, INC. | $36.94 | 2019 | |
| Astrazeneca Pharmaceuticals LP | $30.36 | 2025 | Tezspire |
| Merck Sharp & Dohme LLC | $29.42 | 2025 | Keytruda |
| Intersect Ent, INC. | $25.71 | 2021-2022 | |
| Stryker Corporation | $24.75 | 2021 | |
| Takeda Pharmaceuticals U.S.A., INC. | $21.73 | 2023 |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Resmed Corp | $17.57 | 2019 | |
| Novartis Pharmaceuticals Corporation | $15.98 | 2022 | |
| Med-El Corporation | $15.17 | 2025 | Mi1250 Synchrony 2 Flexsoft, Bci 602 Kit |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Timothy Zajonc listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.